viernes, 20 de noviembre de 2026

Exploring Insulin Cost-Sharing Caps for Patients with Private Coverage Authors: Kaye Pestaina, Faiz Yasin, Michelle Long, Rayna Wallace, and Justin Lo Published: Nov 20, 2026

https://www.kff.org/health-costs/exploring-insulin-cost-sharing-caps-for-patients-with-private-coverage/ Nearly 29 million adults in the U.S. have been diagnosed with diabetes, with 32% of them taking insulin to manage it. The cost of insulin has been a barrier to care for many Americans. A monthly cap on patient cost sharing is one approach aimed at reducing cost-related barriers for people using insulin. While caps do not directly address the underlying price of insulin, they may make patient costs more affordable and support consistent access to this medication. Since 2023, people with Medicare generally have a $35 monthly cap on the cost of insulin. A 2024 KFF poll found that 3 in 4 adults support expanding this cap beyond just those with Medicare. Public support for these protections is also notably bipartisan, with 84% of Democrats and 70% of Republicans in favor.

No hay comentarios: